Loss of function, mutation of the human GRN gene, and insufficient haploidy of PGRN may potentially affect PGRN levels, leading to neurodegenerative diseases such as frontotemporal degeneration (FTLD), neuronal ceroid lipofuscinosis, and Alzheimer’s disease (4, 53, 54). This evidence concerns the gene GRN and neurodegenerative disease.